Cite
HARVARD Citation
Cavalieri, S. et al. (2018). Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer. European journal of cancer. pp. 7-15. [Online].